EE03193B1 - (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks - Google Patents
(1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseksInfo
- Publication number
- EE03193B1 EE03193B1 EE9400387A EE9400387A EE03193B1 EE 03193 B1 EE03193 B1 EE 03193B1 EE 9400387 A EE9400387 A EE 9400387A EE 9400387 A EE9400387 A EE 9400387A EE 03193 B1 EE03193 B1 EE 03193B1
- Authority
- EE
- Estonia
- Prior art keywords
- heteroazolyl
- heterocyclyl
- manufacture
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE19939302332A SE9302332D0 (sv) | 1993-07-06 | 1993-07-06 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE03193B1 true EE03193B1 (et) | 1999-06-15 |
Family
ID=20390539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9400387A EE03193B1 (et) | 1993-07-06 | 1994-11-23 | (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US5731335A (et) |
| EP (1) | EP0707584A1 (et) |
| JP (1) | JPH08512312A (et) |
| CN (1) | CN1126994A (et) |
| AU (1) | AU691506B2 (et) |
| BR (1) | BR9406923A (et) |
| CA (1) | CA2164856A1 (et) |
| CZ (1) | CZ5396A3 (et) |
| EE (1) | EE03193B1 (et) |
| EG (1) | EG20569A (et) |
| FI (1) | FI960076A (et) |
| HU (1) | HUT75097A (et) |
| IL (1) | IL110157A (et) |
| IS (1) | IS4182A (et) |
| MX (1) | MX9405110A (et) |
| NO (1) | NO305955B1 (et) |
| NZ (1) | NZ268689A (et) |
| PL (1) | PL176471B1 (et) |
| RU (1) | RU2124011C1 (et) |
| SE (1) | SE9302332D0 (et) |
| SG (1) | SG64891A1 (et) |
| SK (1) | SK159895A3 (et) |
| WO (1) | WO1995001979A1 (et) |
| ZA (1) | ZA944569B (et) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
| ES2259459T3 (es) | 1997-11-19 | 2006-10-01 | Takeda Pharmaceutical Company Limited | Nuevos inhibidores de apoptosis. |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| CA2400778C (en) * | 2000-03-24 | 2011-05-03 | Euro-Celtique S.A. | Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof |
| BRPI0506749A (pt) | 2004-01-12 | 2007-05-22 | Applied Research Systems | derivados de tiazol e uso dos mesmos |
| RU2392273C2 (ru) * | 2004-09-10 | 2010-06-20 | Синджента Лимитед | Замещенные изоксазолы в качестве фунгицидов |
| US7888376B2 (en) * | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| RU2472788C9 (ru) * | 2007-05-23 | 2013-04-20 | Аллерган, Инк. | (бициклогетероарил)имидазолил)метилгетероарильные соединения как агонисты адренергических рецепторов |
| WO2009123164A1 (ja) * | 2008-04-02 | 2009-10-08 | 塩野義製薬株式会社 | 血管内皮リパーゼ阻害活性を有するヘテロ環誘導体 |
| WO2012010567A1 (en) * | 2010-07-19 | 2012-01-26 | Syngenta Participations Ag | Isoxazole, isothiazole, furane and thiophene compounds as microbicides |
| EP2447261A1 (en) * | 2010-10-29 | 2012-05-02 | Basf Se | Pyrrole, furane and thiophene derivatives and their use as fungicides |
| AU2012300275A1 (en) * | 2011-08-30 | 2014-03-06 | Innocrin Pharmaceuticals, Inc. | Metalloenzyme inhibitor compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58150576A (ja) * | 1982-03-03 | 1983-09-07 | Sumitomo Chem Co Ltd | 新規な１，２，４−オキサジアゾ−ル誘導体 |
| JPH01249760A (ja) * | 1988-03-29 | 1989-10-05 | Yamaha Corp | ホトクロミック化合物 |
| US5068237A (en) * | 1990-05-21 | 1991-11-26 | Warner-Lambert Company | Substituted furans and derivatives thereof acting at muscarinic receptors |
| JPH07502529A (ja) * | 1991-12-31 | 1995-03-16 | 藤沢薬品工業株式会社 | アセチルコリンエステラーゼ阻害およびムスカリン様のアゴニスト活性を有するオキサジアゾール誘導体 |
-
1993
- 1993-07-06 SE SE19939302332A patent/SE9302332D0/xx unknown
-
1994
- 1994-06-23 IS IS4182A patent/IS4182A/is unknown
- 1994-06-24 ZA ZA944569A patent/ZA944569B/xx unknown
- 1994-06-29 IL IL11015794A patent/IL110157A/xx not_active IP Right Cessation
- 1994-07-05 JP JP7503998A patent/JPH08512312A/ja active Pending
- 1994-07-05 SK SK1598-95A patent/SK159895A3/sk unknown
- 1994-07-05 CZ CZ9653A patent/CZ5396A3/cs unknown
- 1994-07-05 EP EP94921147A patent/EP0707584A1/en not_active Withdrawn
- 1994-07-05 CA CA002164856A patent/CA2164856A1/en not_active Abandoned
- 1994-07-05 MX MX9405110A patent/MX9405110A/es not_active IP Right Cessation
- 1994-07-05 RU RU96103659A patent/RU2124011C1/ru active
- 1994-07-05 CN CN94192713A patent/CN1126994A/zh active Pending
- 1994-07-05 BR BR9406923A patent/BR9406923A/pt not_active Application Discontinuation
- 1994-07-05 SG SG1996005493A patent/SG64891A1/en unknown
- 1994-07-05 PL PL94312417A patent/PL176471B1/pl unknown
- 1994-07-05 WO PCT/SE1994/000663 patent/WO1995001979A1/en not_active Application Discontinuation
- 1994-07-05 US US08/379,506 patent/US5731335A/en not_active Expired - Fee Related
- 1994-07-05 AU AU71977/94A patent/AU691506B2/en not_active Ceased
- 1994-07-05 NZ NZ268689A patent/NZ268689A/en unknown
- 1994-07-05 HU HU9503744A patent/HUT75097A/hu unknown
- 1994-07-06 EG EG40594A patent/EG20569A/xx active
- 1994-11-23 EE EE9400387A patent/EE03193B1/et unknown
-
1995
- 1995-06-02 US US08/459,847 patent/US5607956A/en not_active Expired - Fee Related
-
1996
- 1996-01-04 NO NO960028A patent/NO305955B1/no not_active IP Right Cessation
- 1996-01-08 FI FI960076A patent/FI960076A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5731335A (en) | 1998-03-24 |
| CZ5396A3 (en) | 1996-06-12 |
| NO960028D0 (no) | 1996-01-04 |
| SG64891A1 (en) | 1999-05-25 |
| EG20569A (en) | 1999-08-30 |
| SE9302332D0 (sv) | 1993-07-06 |
| PL312417A1 (en) | 1996-04-15 |
| FI960076A0 (fi) | 1996-01-08 |
| IL110157A0 (en) | 1994-10-07 |
| NO305955B1 (no) | 1999-08-23 |
| RU2124011C1 (ru) | 1998-12-27 |
| HUT75097A (en) | 1997-04-28 |
| CA2164856A1 (en) | 1995-01-19 |
| BR9406923A (pt) | 1996-07-30 |
| AU691506B2 (en) | 1998-05-21 |
| FI960076A (fi) | 1996-01-08 |
| WO1995001979A1 (en) | 1995-01-19 |
| MX9405110A (es) | 1995-01-31 |
| IL110157A (en) | 2000-01-31 |
| ZA944569B (en) | 1995-02-15 |
| IS4182A (is) | 1995-01-07 |
| NO960028L (no) | 1996-02-27 |
| PL176471B1 (pl) | 1999-06-30 |
| NZ268689A (en) | 1997-11-24 |
| AU7197794A (en) | 1995-02-06 |
| US5607956A (en) | 1997-03-04 |
| CN1126994A (zh) | 1996-07-17 |
| SK159895A3 (en) | 1996-09-04 |
| EP0707584A1 (en) | 1996-04-24 |
| JPH08512312A (ja) | 1996-12-24 |
| HU9503744D0 (en) | 1996-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO952618D0 (no) | Xerogeler, fremgangsmåte for fremstilling derav samt deres anvendelse | |
| FI941137A (fi) | 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi | |
| EE03482B1 (et) | Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine | |
| EE03231B1 (et) | Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine | |
| FI945166A0 (fi) | Katalyttejä, niiden käyttömenetelmä ja menetelmä niiden valmistamiseksi | |
| NO944187D0 (no) | Isokinoliner, fremgangsmåte for deres fremstilling og anvendelse | |
| ITRM920412A1 (it) | Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico. | |
| ITMI921488A0 (it) | Granulati, processo per la loro preparazione e loro impiego | |
| EE9600172A (et) | Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid | |
| FI944600A (fi) | Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa | |
| DK0562583T3 (da) | Hidtil ukendte alkylendiammoniumdiclavulanatderivater, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
| EE03193B1 (et) | (1-heteroasolüül-1-heterotsüklüül)alkaani derivaadid, nende saamise protsessid ja nende kasutamine närvisüsteemi kaitsvate vahendite valmistamiseks | |
| NO953673L (no) | [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse | |
| FI941196A (fi) | Saattohinaukseen ja/tai satamakäyttöön tarkoitettu hinaaja | |
| FI941914A (fi) | 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö | |
| BR9400338A (pt) | Processo para preparação de 1,1,1,2-tetrafluoro-2-cloroetano e de pentafluoretano | |
| FI953956A0 (fi) | 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| NO940130D0 (no) | Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav | |
| NO900643L (no) | Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater. | |
| FI961977A (fi) | N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö | |
| FI102169B1 (fi) | 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina | |
| FI960077A (fi) | Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina | |
| NO942230D0 (no) | Substituerte benzimidazoler, fremgangsmåte for deres fremstilling samt deres anvendelse | |
| NO962243D0 (no) | Halogenarylsubstituerte metallkomplekser, farmasöytiske midler inneholdende slike og deres anvendelse i diagnostikken, samt fremgangsmåte for fremstilling av slike komplekser og midler | |
| IL111707A0 (en) | Substituted benzimidazole, processes for its preparation and its pharmaceutical use |